These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24589194)

  • 1. Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel.
    Anderson TJ; Grégoire J; Hegele RA; Couture P; Mancini GB; McPherson R; Francis GA; Poirier P; Lau DC; Grover S; Genest J; Carpentier AC; Dufour R; Gupta M; Ward R; Leiter LA; Lonn E; Ng DS; Pearson GJ; Yates GM; Stone JA; Ur E
    Can J Cardiol; 2014 Apr; 30(4):377-80. PubMed ID: 24589194
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment with hydroxymethylglutaryl coenzyme-A-reductase inhibitors in elderly patients: is it necessary?].
    Alexa ID; Panaghiu L; Ungureanu G
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(4):721-6. PubMed ID: 16610166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol treatment and changes in guidelines in an academic medical practice.
    Schoen MW; Salas J; Scherrer JF; Buckhold FR
    Am J Med; 2015 Apr; 128(4):403-9. PubMed ID: 25460526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of dyslipidemia in 2014: European versus American guidelines].
    Radermecker RP
    Rev Med Suisse; 2014 Aug; 10(439):1534-7. PubMed ID: 25272669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new dyslipidemia guidelines: what is the debate?
    Anderson TJ; Mancini GB; Genest J; Grégoire J; Lonn EM; Hegele RA
    Can J Cardiol; 2015 May; 31(5):605-12. PubMed ID: 25816728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating dyslipidemia in the high-risk patient.
    Jones PH
    J Fam Pract; 2010 Feb; 59(2):E1. PubMed ID: 20141719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia: executive summary.
    Expert Panel on Dyslipidemia
    Atherosclerosis; 2014 Feb; 232(2):410-3. PubMed ID: 24468156
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment for dyslipidemia--a strategy for the prevention of atherosclerosis].
    Seishima M
    Rinsho Byori; 2013 Apr; 61(4):334-41. PubMed ID: 23855190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
    Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
    Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines in the USA, a viewpoint contrary to those guidelines in Europe, Canada, Britain and the International Atherosclerosis Society.
    Saraf S; Ray KK
    Curr Opin Lipidol; 2014 Dec; 25(6):413-7. PubMed ID: 25268983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of atherosclerosis demands low LDL targets and raised HDL levels.
    Cardiovasc J Afr; 2008; 19(4):221. PubMed ID: 18776971
    [No Abstract]   [Full Text] [Related]  

  • 13. The new pooled cohort equations risk calculator.
    Preiss D; Kristensen SL
    Can J Cardiol; 2015 May; 31(5):613-9. PubMed ID: 25843167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDL as a therapeutic objective.
    Díaz Rodríguez Á; Mantilla Morató T
    Clin Investig Arterioscler; 2019 Dec; 31 Suppl 2():1-15. PubMed ID: 31813617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of dyslipidemia in clinical practice].
    Paragh G; Harangi M
    Orv Hetil; 2006 Mar; 147(9):389-94. PubMed ID: 16619956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Stone NJ; Robinson JG; Lichtenstein AH; Bairey Merz CN; Blum CB; Eckel RH; Goldberg AC; Gordon D; Levy D; Lloyd-Jones DM; McBride P; Schwartz JS; Shero ST; Smith SC; Watson K; Wilson PW;
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt B):2889-934. PubMed ID: 24239923
    [No Abstract]   [Full Text] [Related]  

  • 17. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipids and Cerebrovascular Disease: Research and Practice.
    Yaghi S; Elkind MS
    Stroke; 2015 Nov; 46(11):3322-8. PubMed ID: 26451029
    [No Abstract]   [Full Text] [Related]  

  • 19. The 2018 ACC/AHA Lipid Guidelines: A Little More or Less Canadian?
    Thanassoulis G; Gregoire J; Pearson GJ
    Can J Cardiol; 2019 May; 35(5):558-563. PubMed ID: 31030858
    [No Abstract]   [Full Text] [Related]  

  • 20. Merits and potential downsides of the 2013 ACC/AHA cholesterol management guidelines.
    Gotto AM; Moon JE
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):573-6. PubMed ID: 24819819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.